Your browser doesn't support javascript.
loading
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients.
Khunger, Monica; Patil, Pradnya Dinkar; Khunger, Arjun; Li, Manshi; Hu, Bo; Rakshit, Sagar; Basu, Arnab; Pennell, Nathan; Stevenson, James P; Elson, Paul; Panchabhai, Tanmay S; Velcheti, Vamsidhar.
Afiliación
  • Khunger M; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Patil PD; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Khunger A; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Li M; Department of Quantitate Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America.
  • Hu B; Department of Quantitate Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America.
  • Rakshit S; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Basu A; Department of Hematology and Oncology, University of Southern California, Los Angeles, California, United States of America.
  • Pennell N; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Stevenson JP; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Elson P; Department of Quantitate Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America.
  • Panchabhai TS; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States of America.
  • Velcheti V; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
PLoS One ; 13(10): e0197743, 2018.
Article en En | MEDLINE | ID: mdl-30359383
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos